Finally, we show that intratumoural delivery of our senolytic and a Braf inhibitor can successfully eliminate early melanomas in a mouse model resulting in increased survival and systemic delivery of our senolytic can eliminate senescent cells in old mice. The gene discussed is BRAF; the disease is melanoma.